1. Aubourgh MD, Derome PJ, Peillon F, Jedynak CP, Visot A, Le Gentil P, Balagura S, Guiot G (1980) Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumour size as predicting factors. Surg Neurol 14: 141 – 152
2. Barbarino A, De Marinis L, Anile C (1982) Dopaminergic mechanism regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery. Metabolism 31: 1100–1104
3. Barnard LB (1986) Reduction of pituitary tumour size in acromegaly treated with a somatostatin analogue (SMS 201–995): Abst 983 in The 68th Annual Meeting of the Endocrine Society, Anaheim
4. Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E (1984) Clinical and pathological effects of bromocriptine on prolactin secreting and other pituitary tumours. J Neurosurg 60: 1 – 7
5. Bassetti M, Spada A, Pezzo G, Giannattasio G (1984) Bromocriptine treatment reduces the cell size in human macroprolactinomas: A morphometric study. J Clin Endocr 58: 268–273